Program of the 1991 Annual Meeting, Genes, Cancer and Radiation Protection
April 3-4, 1991
Introduction
Mortimer L. Mendelsohn, Chair
Radiation Induced Cancer Risk Estimation, Today and Tomorrow
Warren K. Sinclair, NCRP
Carcinogenesis: Overview
Michael N. Gould, University of Wisconsin
Radiation Mechanisms (Damage, Repair and Mutagenesis)
S. James Adelstein, Chair
Radiation Tracks in Biological Material: Initial Damage in Cells, DNA and Associated Structures
Dudley Goodhead, Medical Research Council, United Kingdom
The Intracellular Molecular Damage Which is Dependent on Radiation Energy Deposition Patterns at the Nanometer Level
John Ward, University of California, San Diego
Genetic Regulation of Base Damage and Double Strand Break in Human Cells and Associated Human Genetic Disorders
James Cleaver, University of California, San Francisco
Molecular Characterization of Radiation Induced Specific Locus Mutations In Vitro
Amy Kronenberg, Lawrence Livermore National Laboratory
Genetic Aspects of Carcinogenesis
R.J. Michael Fry, Chair
Clonal Chromosome Aberrations in Human Leukemia: Markers of Mutagenic Exposure
Janet D. Rowley, University of Chicago
The Role of Tumor Suppressor Genes in Second Malignancies
Stephen Friend, Massachusetts General Cancer Center
The Genetic Changes on Ras Oncogenes in Radiation Induced Lymphomas
Angel Pellicer, New York University School of Medicine
Biological Dosimetry
Michael A. Bender, Chair
Applications of Molecular Cytogenetic Techniques in Radiation Dosimetry
Joe Gray, Lawrence Livermore National Laboratory
Somatic Gene Mutation in the Human in Relation to Radiation Risk
Mortimer L. Mendelsohn, Lawrence Livermore National Laboratory
Fifteenth Lauriston S. Taylor Lecture on Radiation Protection and Measurements
Introduction of the Lecturer, Charles B. Meinhold
When is a Dose Not a Dose?, Victor P. Bond
Epidemiology
Arthur C. Upton, Chair
Epidemiological Applications
Fred Li, National Cancer Institute, Dana Farber Cancer Center
Altered Proto-oncogenes and Tumor Suppressor Genes in “Normal” Tissues of People Exposed to Radium
Eliezer Huberman, Argonne National Laboratory
Conclusion
Mortimer L. Mendelsohn, Chair
Risky Genes, What do they Mean?
John D. Boice, Jr., National Cancer Institute